Skip to main content
Journal of Medical BiochemistryVolume 36, Issue 4, 28 August 2017, Pages 358-365

Alterations of HDL Particles in Children with End-Stage Renal Disease(Article)(Open Access)

  • Stefanović, A.,
  • Ristovski-Kornic, D.,
  • Kotur-Stevuljević, J.,
  • Spasojević-Kalimanovska, V.,
  • Vekić, J.,
  • Miljković, M.,
  • Paripović, D.,
  • Peco-Antic, A.,
  • Jelić-Ivanović, Z.,
  • Zeljković, A.
  • View Correspondence (jump link)
  Save all to author list
  • aDepartment of Medical Biochemistry, Faculty of Pharmacy, University of Belgrade, Belgrade, Serbia
  • bHealth Center Pancevo, Pančevo, Serbia
  • cDepartment of Nephrology, University Children's Hospital, Belgrade, Serbia
  • dMedical Faculty, University of Belgrade, Belgrade, Serbia

Abstract

Background: Unfavorable lipid profile presents one of most important risk factor for cardiovascular disease in renal pathology. Myeloperoxidase (MPO) as enzyme which oxidizes lipoproteins and paraoxonase1 (PON1) as anti-oxidative enzyme have been involved in pathogenesis of cardiovascular disease. In the present study we sought to assess oxidative stress status, lipoprotein subclasses distribution as well as functionality of high density lipoprotein (HDL) trough MPO/PON1 ratio in children with chronic kidney disease (CKD) and children after renal transplantation. Methods: PON1 activity and oxidative stress parameters were measured spectrophotometrically, while MPO concentration was determined using immunoassay. Separation of lipoprotein subclasses was performed by vertical gradient gel electrophoresis in 19 children with different stage of CKD and 19 post-transplantation patients (PT). Results: CKD patients had increased MPO/PON1 ratio and higher prevalence of smaller HDL subclasses when compared to PT subjects. Also, there was a significant positive correlation between MPO level and MPO/PON1 ratio with relative proportion of smaller HDL subclasses. Conclusion: Children with CKD have impaired HDL distribution that is improved after kidney transplantation. Since that measurement of HDL distribution and functionality are not routinely available, MPO/PON1 ratio may be useful marker that could provide necessary information. © by Aleksandra Stefanović 2017.

Author keywords

chronic kidney diseaseHDL particlesmyeloperoxidase

Indexed keywords

EMTREE drug terms:adiponectinadvanced oxidation protein productapolipoprotein A1apolipoprotein B100aryldialkylphosphatase 1high density lipoproteinhigh density lipoprotein cholesterolleptinlow density lipoprotein cholesterolmyeloperoxidasethiobarbituric acid reactive substancetriacylglycerol
EMTREE medical terms:adolescentadultArticlechildcholesterol blood levelclinical articlecontrolled studyelectrophoretic mobilityend stage renal diseasefemalegel electrophoresishumankidney transplantationmaleoxidative stressparticle sizewaist hip ratio

Chemicals and CAS Registry Numbers:

adiponectin, 283182-39-8; myeloperoxidase

Funding details

Funding sponsor Funding number Acronym
Ministarstvo Prosvete, Nauke i Tehnološkog Razvoja175035MPNTR
  • 1

    Research funding: This work is supported by

  • ISSN: 14528258
  • Source Type: Journal
  • Original language: English
  • DOI: 10.1515/jomb-2017-0019
  • Document Type: Article
  • Publisher: Society of Medical Biochemists of Serbia and Montenegro

  Stefanović, A.; Department of Medical Biochemistry, Faculty of Pharmacy, University of Belgrade, Belgrade, Serbia;
© Copyright 2017 Elsevier B.V., All rights reserved.

Cited by 6 documents

Xu, Z. , Yang, S. , Cui, L.
Understanding the heterogeneity and dysfunction of HDL in chronic kidney disease: insights from recent reviews
(2024) BMC Nephrology
Gliwińska, A. , Ćwiklińska, A. , Czaplińska, M.
Changes in the size and electrophoretic mobility of HDL subpopulation particles in chronic kidney disease
(2023) Journal of Nephrology
Coimbra, S. , Reis, F. , Valente, M.J.
Subpopulations of high-density lipoprotein: Friends or foes in cardiovascular disease risk in chronic kidney disease?
(2021) Biomedicines
View details of all 6 citations
{"topic":{"name":"Aryldialkylphosphatase; Paraoxonase; Enzyme","id":4511,"uri":"Topic/4511","prominencePercentile":87.89521,"prominencePercentileString":"87.895","overallScholarlyOutput":0},"dig":"e3e50e005646e2959adf99e2260d123389ddba4c89c357b85167f1b7fc61ab6c"}

SciVal Topic Prominence

Topic:
Prominence percentile: